GURUFOCUS.COM » STOCK LIST » Utilities » Utilities - Independent Power Producers » Orion Pharma Ltd (DHA:ORIONPHARM) » Definitions » Debt-to-Revenue

Orion Pharma (DHA:ORIONPHARM) Debt-to-Revenue : 2.61 (As of Dec. 2023)


View and export this data going back to 2013. Start your Free Trial

What is Orion Pharma Debt-to-Revenue?

Debt-to-Revenue measures a company's ability to pay off its debt.

Orion Pharma's Short-Term Debt & Capital Lease Obligation for the quarter that ended in Dec. 2023 was BDT3,477 Mil. Orion Pharma's Long-Term Debt & Capital Lease Obligation for the quarter that ended in Dec. 2023 was BDT18,788 Mil. Orion Pharma's annualized Revenue for the quarter that ended in Dec. 2023 was BDT8,542 Mil. Orion Pharma's annualized Debt-to-Revenue for the quarter that ended in Dec. 2023 was 2.61.


Orion Pharma Debt-to-Revenue Historical Data

The historical data trend for Orion Pharma's Debt-to-Revenue can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Orion Pharma Debt-to-Revenue Chart

Orion Pharma Annual Data
Trend Dec13 Dec14 Jun16 Jun17 Jun18 Jun19 Jun20 Jun21 Jun22 Jun23
Debt-to-Revenue
Get a 7-Day Free Trial Premium Member Only Premium Member Only 0.94 1.80 1.56 1.93 1.57

Orion Pharma Quarterly Data
Mar19 Jun19 Sep19 Dec19 Mar20 Jun20 Sep20 Dec20 Mar21 Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23
Debt-to-Revenue Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 1.32 2.46 1.47 1.52 2.61

Competitive Comparison of Orion Pharma's Debt-to-Revenue

For the Utilities - Independent Power Producers subindustry, Orion Pharma's Debt-to-Revenue, along with its competitors' market caps and Debt-to-Revenue data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Orion Pharma's Debt-to-Revenue Distribution in the Utilities - Independent Power Producers Industry

For the Utilities - Independent Power Producers industry and Utilities sector, Orion Pharma's Debt-to-Revenue distribution charts can be found below:

* The bar in red indicates where Orion Pharma's Debt-to-Revenue falls into.



Orion Pharma Debt-to-Revenue Calculation

Debt-to-Revenue measures a company's ability to pay off its debt.

Orion Pharma's Debt-to-Revenue for the fiscal year that ended in Jun. 2023 is calculated as

Debt-to-Revenue=Total Debt / Revenue
=(Short-Term Debt & Capital Lease Obligation + Long-Term Debt & Capital Lease Obligation) / Revenue
=(1062.228 + 20834.406) / 13926.596
=1.57

Orion Pharma's annualized Debt-to-Revenue for the quarter that ended in Dec. 2023 is calculated as

Debt-to-Revenue=Total Debt / Revenue
=(Short-Term Debt & Capital Lease Obligation + Long-Term Debt & Capital Lease Obligation) / Revenue
=(3477.45 + 18787.524) / 8542.188
=2.61

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

In the calculation of annual Debt-to-Revenue, the Revenue of the last fiscal year is used. In calculating the annualized quarterly data, the Revenue data used here is four times the quarterly (Dec. 2023) Revenue data.


Orion Pharma Debt-to-Revenue Related Terms

Thank you for viewing the detailed overview of Orion Pharma's Debt-to-Revenue provided by GuruFocus.com. Please click on the following links to see related term pages.


Orion Pharma (DHA:ORIONPHARM) Business Description

Traded in Other Exchanges
N/A
Address
153-154 Tejgaon Industrial Area, Dhaka, BGD, 1208
Orion Pharma Ltd is a pharmaceutical company engaged in the manufacturing and marketing of pharmaceutical drugs and medicines. It provides its drugs in various dosage forms including tablet, capsule, syrup, suspension, injection, dry powder for syrup and suspension, for therapeutic groups like anticancer, antibiotics, antidiabetics, anxiolytics, diuretics, cardiovascular drugs, and others. In addition, the company is also involved in power generation activities. It generates maximum revenue from power generation activities. The group principally carries out its business operations and markets its products in Bangladesh.

Orion Pharma (DHA:ORIONPHARM) Headlines

No Headlines